- Report
- October 2020
- 37 Pages
India
From €4761EUR$4,995USD£4,084GBP
- Report
- October 2020
- 38 Pages
Germany
From €4761EUR$4,995USD£4,084GBP
- Report
- December 2020
- 342 Pages
Spain
From €5714EUR$5,995USD£4,902GBP
- Report
- December 2020
- 334 Pages
South Korea
From €5714EUR$5,995USD£4,902GBP
- Report
- December 2020
- 336 Pages
Russia
From €5714EUR$5,995USD£4,902GBP
- Report
- December 2020
- 327 Pages
Mexico
From €5714EUR$5,995USD£4,902GBP
- Report
- December 2020
- 351 Pages
Japan
From €5714EUR$5,995USD£4,902GBP
- Report
- December 2020
- 348 Pages
Italy
From €5714EUR$5,995USD£4,902GBP
- Report
- December 2020
- 376 Pages
France
From €5714EUR$5,995USD£4,902GBP
- Report
- December 2020
- 335 Pages
Brazil
From €5714EUR$5,995USD£4,902GBP
- Report
- October 2020
- 37 Pages
Brazil
From €4761EUR$4,995USD£4,084GBP
- Report
- October 2020
- 36 Pages
Mexico
From €4761EUR$4,995USD£4,084GBP
- Report
- October 2020
- 38 Pages
Japan
From €4761EUR$4,995USD£4,084GBP
- Report
- October 2020
- 38 Pages
China
From €4761EUR$4,995USD£4,084GBP
- Report
- October 2020
- 37 Pages
South Korea
From €4761EUR$4,995USD£4,084GBP
- Report
- October 2020
- 37 Pages
Russia
From €4761EUR$4,995USD£4,084GBP
- Report
- October 2020
- 38 Pages
Spain
From €4761EUR$4,995USD£4,084GBP
- Report
- October 2020
- 37 Pages
Italy
From €4761EUR$4,995USD£4,084GBP
- Report
- October 2020
- 44 Pages
France
From €4761EUR$4,995USD£4,084GBP
- Report
- October 2020
- 37 Pages
United Kingdom
From €4761EUR$4,995USD£4,084GBP
Within the realm of cardiovascular devices, mechanical circulatory support (MCS) devices are engineered to assist or replace the pumping function of the heart in patients with severe heart failure or during cardiac procedures. This subset of devices encompasses a range of products including ventricular assist devices (VADs), total artificial hearts (TAHs), and intra-aortic balloon pumps (IABPs). The market for MCS devices is driven by technological advancements, the prevalence of heart failure, and the need for supportive interventions in cardiac surgeries. VADs can be utilized as a bridge to transplantation, a bridge to recovery, or as a destination therapy, catering to different patient needs. Ongoing research and development aim at improving the durability, biocompatibility, and functionality of these devices, thereby enhancing patient outcomes and quality of life.
Several companies are recognized contributors in the mechanical circulatory support devices market. Notable among them is Medtronic, which offers a range of cardiac and vascular therapies. St. Jude Medical, now part of Abbott Laboratories, provides various MCS solutions after Abbott's acquisition. Thoratec Corporation, acquired by St. Jude Medical, was historically a specialist in VADs. SynCardia Systems, Inc. is known for their total artificial heart as a bridge to transplant. Berlin Heart GmbH offers ventricular assist devices catering to both adult and pediatric patients. Lastly, MAQUET Holding B.V. & Co. KG, part of the GETINGE GROUP, provides intra-aortic balloon Show Less Read more